logo
The simple 30-second finger test that can reveal your risk of devastating incurable disease

The simple 30-second finger test that can reveal your risk of devastating incurable disease

The Sun06-05-2025
JOINT flexibility is important for healthy movement and function.
But being able to move your joints in an extraordinary way could be a sign of Ehlers-Danlos syndromes (EDS).
3
EDS are a group of inherited disorders that affect connective tissues, primarily the skin, joints, and blood vessels.
These disorders result from genetic mutations that impact the production or structure of collagen, a key protein that provides support and structure to various tissues.
EDS is characterised by joint hypermobility - an increased range of motion in the joints, making them more flexible than average.
Skin can stretch further than normal, joints bend too far and sometimes dislocate, and internal tissues bruise or tear more easily.
According to Jeannie Di Bon, a UK-based hypermobility and EDS specialist, just because you're hypermobile doesn't automatically mean something's wrong with your connective tissue or that you've got a syndrome.
But if hypermobility begins to really bother you and suddenly becomes very problematic (often overnight), it could be cause for investigation for a connective tissue disorder, such as EDS, Di Bon told Newsweek.
Easy test for hypermobility
3
The nine-point Beighton score is a simple assessment tool used to evaluate joint hypermobility.
It involves testing the flexibility of several joints, with each positive result adding a point to the score.
A higher score generally indicates greater joint hypermobility.
The score is calculated by adding up the points earned for each of the five tests.
What is Raynaud's disease?
If the finger can be bent back more than 90 degrees - one point for each hand.
If the thumb can be bent backward so that it touches or goes beyond the palm of the hand or wrist - one point for each hand.
Being able to extend the elbow beyond 10 degrees - one point for each elbow.
Being able to extend the knee beyond 10 degrees - one point for each knee.
The ability to bend forward from the waist, with knees fully extended, and touch the palms flat on the floor - one point if the palms can touch the floor.
A score of more than five out of nine, for an adult, indicates a person has hypermobility.
For a child, it's a score of at least six out of nine.
The score alone doesn't confirm EDS.
A hypermobile-EDS diagnosis is "based on a checklist where the patient meets certain criteria, including a Brighton score level," Dr Bernadette Riley, director of the Ehlers‑Danlos Syndrome/Hypermobility Treatment Center at New York Institute of Technology's College of Osteopathic Medicine, told Newsweek.
Official figures for diagnosed cases of EDS in the UK are around 135,000 to 300,000.
The actual number of people living with the condition is likely higher due to underdiagnosis and misdiagnosis.
EDS can manifest at different ages, depending on the specific type, with some forms being evident at birth and others not being diagnosed until adulthood.
While symptoms of inherited EDS can be present at birth, they may not be noticeable until puberty.
Some milder forms are often not diagnosed until early adulthood, while more severe types are typically diagnosed in childhood.
Symptoms of Ehlers-Danlos Syndromes
Ehlers-Danlos syndromes (EDS) are a group of rare inherited conditions that affect connective tissue.
Connective tissues provide support in skin, tendons, ligaments, blood vessels, internal organs and bones.
EDS can affect people in different ways. For some, the condition is relatively mild, while for others their symptoms can be disabling.
Different types of EDS are caused by faults in certain genes that make connective tissue weaker.
There are 13 types of EDS, most of which are rare. Hypermobile EDS (hEDS) is the most common type.
Several types of EDS may share some symptoms.
These include:
an increased range of joint movement (joint hypermobility)
stretchy skin
fragile skin that breaks or bruises easily
If you suspect symptoms of EDS, speak to your GP.
Source: NHS
People with EDS have also been found to be more susceptible to respiratory issues, including a range of symptoms from shortness of breath and exercise limitations to conditions like pneumothorax.
A 2022 study published in Respiratory Medicine and Research found that almost 85 percent of EDS patients had signs of respiratory problems.
And mental health conditions are also widely reported among EDS patients.
Another 2022 study found almost half of the EDS patients surveyed had depression and over half had "probable" anxiety.
There's no cure for EDS, however, various treatments and lifestyle adjustments can help manage symptoms, prevent complications, and improve quality of life.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Are YOUR dizzy spells being caused by hidden nervous system problems that GPs often fail to spot... and could the cure be a 30p pill?
Are YOUR dizzy spells being caused by hidden nervous system problems that GPs often fail to spot... and could the cure be a 30p pill?

Daily Mail​

time5 hours ago

  • Daily Mail​

Are YOUR dizzy spells being caused by hidden nervous system problems that GPs often fail to spot... and could the cure be a 30p pill?

For more than 20 years, mother-of-two Kerry Clayton endured dizzy spells, fainting and constant light-headedness – only to have her concerns repeatedly dismissed by doctors. Her symptoms first appeared in her teens when she fainted during an exam. At the time, it was put down to stress. But the episodes kept happening – at work, in busy crowds – until they became, as she puts it, 'part of everyday life'.

Fat jabs like Ozempic and Mounjaro threaten to push up pension age as life expectancy rises
Fat jabs like Ozempic and Mounjaro threaten to push up pension age as life expectancy rises

Daily Mail​

time5 hours ago

  • Daily Mail​

Fat jabs like Ozempic and Mounjaro threaten to push up pension age as life expectancy rises

The spread of 'fat jabs' such as Ozempic could lead to a rise in the state pension age because previously obese workers will live longer than expected, Government advisers have warned. With more than 1.5 million people now using weight-loss drugs in the UK, the number-crunchers say that actuarial calculations about life expectancy – and therefore the bill faced by the Department for Work and Pensions – will have to be adjusted. Users of the drugs, which also include Mounjaro and Wegovy, typically lose about 15 per cent of their body weight, leading to knock-on health benefits such as lower cholesterol levels and reduced blood pressure. Health Secretary Wes Streeting aims to widen the availability of the drugs on the NHS to lessen the burden on the Health Service and boost employment, arguing that 'our widening waistbands' are 'holding back our economy'. Illness as a result of obesity causes people to take an extra four sick days a year on average. But a Government source told The Mail on Sunday: 'Obviously everyone can see the health benefits. But some people in the Treasury are worried about the impact on the pension crisis. Obesity is a big killer. 'And if people are starting to live a lot longer because they're not overweight that's quickly going to become an issue. Especially if we're going to see it regularly being prescribed on the NHS, as Wes is advocating.' The NHS currently offers the medicines for the management of obesity in certain patients. With more than 1.5 million people now using weight-loss drugs in the UK, the number-crunchers say that actuarial calculations about life expectancy – and therefore the bill faced by the Department for Work and Pensions – will have to be adjusted (file image) The state pension age will officially rise next year from 66 to 67, and then again to 68 between 2044 and 2046 – although growing pressure on public funds means an upcoming pension review by Work and Pensions Secretary Liz Kendall could hike that age further. Chancellor Rachel Reeves is facing a £50billion 'fiscal hole' in the public finances she will need to close in Autumn's Budget: measures considered include tighter inheritance tax rules and an increase in 'sin taxes' on tobacco and gambling. The triple lock protection for the state pension is also becoming a growing burden, with spiking inflation predicted to push the full amount to £12,451 next year – a £478 rise from its current level of £11,973. According to the forecasts, the state pension will cost the Exchequer £151.42 billion that year – £430 million higher than the £150.99 billion bill anticipated as a result of previous Bank Of England inflation forecasts. Mr Streeting hopes the weight-loss jabs will ease the burden on the NHS' budget, which will rise by 3.3 per cent next year to £192 billion.

Surge in cannabis-induced psychotic episodes across the UK as potency of strains has increased
Surge in cannabis-induced psychotic episodes across the UK as potency of strains has increased

Daily Mail​

time5 hours ago

  • Daily Mail​

Surge in cannabis-induced psychotic episodes across the UK as potency of strains has increased

Cannabis-induced psychosis is becoming increasingly common across the UK, a leading psychiatrist has warned. The widely used class B drug – also known as marijuana or weed – can cause dependency, and, in the year to March 2024, 2.3million people in the UK reported using it. But while regular use has more than halved in the past two decades, the number of cannabis-induced psychosis episodes has spiked as varieties on sale have become stronger. Those experiencing a psychotic episode commonly have symptoms such as hallucinations, dissociation or unusual changes in behaviour. And while these resolve in most cases, side-effects can last for years. Studies show cannabis can even trigger schizophrenia – a chronic mental health condition characterised by psychotic episodes where individuals lose touch with reality, experiencing delusions and hallucinations. Dr Niall Campbell, a consultant psychiatrist at the Priory rehabilitation centre, warns of a deepening public health issue, stemming from easy online access to highly potent forms of the drug known as 'skunk'. Made from unpollinated cannabis plants which naturally contain higher levels of THC – the main psychoactive ingredient – skunk greatly increases the risk of paranoia and hallucinations. 'There has been a visible rise in the number of people needing intensive support for psychosis as a result of cannabis use,' said Dr Campbell. 'I don't think this is surprising given how easy skunk is to buy. What begins with smoking a few 'joints' and feeling a bit paranoid can easily escalate. Over time people can reach a psychotic state which won't go away, even if they stop smoking – they can become very depressed or suicidal.' It comes after the London Drugs Commission released a report earlier this year calling for more services to tackle cannabis addiction.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store